Krones Cuts the Growth Story, Not Yet the Margin Story
Three months after defending its €7 billion 2028 target, Krones resets growth to €6.0–6.2 billion and leans on backlog, price discipline and German early-retirement accruals to protect profitability.
KRN.DE · Earnings Call · 2026-11-06
The promise that didn't survive the quarter
On 6 November, Krones opened with the anodyne line that it had delivered 'moderate growth and improved profitability in a challenging market environment.' The real news was three weeks old: on 22 October the board cut 2026 revenue growth guidance from 3–5% to 1–2% and reset the 2028 revenue target from around €7 billion to €6.0–6.2 billion. “the Board of Krones decided at the 22nd of October to adjust our revenue growth forecast for 2026 and also for the medium-term target for 2028” — Thomas Ricker, CEO · 2026-11-06. CFO Uta Anders was blunter about the near-term number: “we decided on the 22nd of October that we have to adjust our growth guidance for 2026 from originally 3% to 5% to now 1% to 2%” — Uta Anders, CFO · 2026-11-06. The margin and ROCE targets were retained and specified—including an 11–12% EBITDA margin target for 2028—so management is asking investors to separate growth from profitability. That is the pivot: Krones is no longer selling a recovery in beverage capex; it is selling defense of margin in a slower cycle. The contrast with prior calls is stark. In February, then-CEO Christoph Klenk was emphatic: “we stay with the targets of around EUR 7 billion in 2028. That's important.” — Christoph Klenk, CEO or Managing Director · 2026-02-19 In July, Anders acknowledged the target was harder but refused to surrender it: “there are impacts which we had not seen back in 2024. But on the other hand, I would not take them back right now.” — Uta Anders, CFO or Finance Executive · 2026-07-29 Three months later they did take it back, and by more than the FX/Netstal bridge analysts had modeled. New CEO Thomas Ricker did not hide the awkwardness: 'maybe I share a bit your surprise.' The growth guidance cut is therefore not a routine trim; it is a public admission that the 2028 plan was built on a different world.Backlog, price, and the U.S. turn
Operationally, Krones is not in freefall. Order intake for the first nine months was €4.224 billion, up 2.9%, with a book-to-bill of 1.03x and an order backlog of around €4.3 billion, up about 3%. That backlog extends into 2027 and beyond, and management leaned on it repeatedly as the visibility anchor. Revenue in Q3 was essentially flat at €1.385 billion; for the nine months, FX-adjusted growth was 0.8%. EBITDA margin was 11.1%, or 10.8% normalized for tariff effects, and free cash flow was minus €5 million—Q4-loaded, as usual. The regional message was more nuanced than the headline. The U.S. market is showing signs of a turn after the tariff shock: Ricker said tariffs are 'still there, but it's much better plannable at the moment,' which is why order intake in the Americas has stabilized. Asia Pacific remains the structural growth region, with China stabilizing and India's new plants opened but not yet material to 2027. Europe held up well; the weak spots were Central Asia, the Middle East and Africa against a high base, and China in absolute mix. The most important defense is price. Krones has spent years arguing it would not buy volume. Ricker repeated that Krones is 'the price leader in our industry' and must defend that position, but he also conceded the obvious: “the risk of a price war is every time given, especially if volumes overall are a bit more reduced” — Thomas Ricker, CEO · 2026-11-06. That is the tension inside the price discipline story. With filling and packaging revenue now guided to minus 1% to plus 1%, the company is testing whether discipline survives a slower order environment.The margin story has a Q4 catch
The segment mix explains why the margin held. Intralogistics grew 10% in the nine months, and management raised its full-year growth guidance to 10–15%, with an EBITDA margin target of 7.5–8.5%. Process Technology grew 4.2% and kept its 9–10% margin guide. Filling and Packaging, the largest segment, was the problem child: revenue fell slightly in Q3 and the growth guide was cut. Group EBITDA guidance of 10.7–11.1% was confirmed, but Q4 will be below the year-to-date level because of a new item: flexibility measures. Anders described a “one-time effect in the mid- to high EUR 1 million digit number for some flexibility measures” — Uta Anders, CFO · 2026-11-06 tied to German early-retirement accruals—cheap headcount flexibility, not operating leverage. That is a subtle change in language. Prior calls talked about service technicians, FTE growth and personnel-cost ratios; this quarter introduced 'flexibility measures' as a margin-management tool. It is prudent, but it also signals that the growth deleverage is real. Working capital remains elevated at 18.9% of revenue, with inventory at 13.5% and payables lower; management expects Q4 to release cash, pointing to the historical average Q4 free cash flow of €190 million. ROCE of 17.6% is already feeling the lack of growth because capital employed is higher.That is the cleanest explanation of the reset: it is not one thing. It is injection molding below plan, turnkey brewery projects below plan, longer customer decision times, and a higher cost base for customers. The missing keyword is telling: Netstal and injection molding, which dominated prior calls as the dilutive acquisition and the key to closing the PET loop, barely appear in the current top keyword set. The problem child has been folded into a generic 'injection molding is not as we had seen' line rather than a standalone debate. Investors should notice what management stopped emphasizing.Whilst you're talking about EUR 1 billion... We don't see currently a stabilization on the geopolitical situation, and we don't see currently also a big stabilization on the, let me say, uncertainty side globally, including the cost increases mainly on the oil price, but then on the second part, directly also influencing our customers with their increased cost of raw materials.